Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03639714
Title A Study of a Personalized Neoantigen Cancer Vaccine
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Gritstone Oncology, Inc.
Indications

lung non-small cell carcinoma

gastroesophageal junction adenocarcinoma

transitional cell carcinoma

colorectal cancer

Therapies

GRT-C901 + GRT-R902 + Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona Phoenix Arizona 85054 United States Details
Mayo Clinic Jacksonville Florida 32224 United States Details
The University of Chicago Chicago Illinois 60637 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10017 United States Details
Columbia University Medical Center New York New York 10032 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field